Literature DB >> 7733190

Hypertension and lens opacities from the Beaver Dam Eye Study.

B E Klein1, R Klein, S C Jensen, K L Linton.   

Abstract

PURPOSE: To examine the relationship between hypertension and lens opacities, and the use of antihypertensive agents.
METHODS: A total of 4,926 adults, 43 to 84 years of age, living in Beaver Dam, Wisconsin, at the time of a private census, were invited to participate in a study that included a medical interview and an examination that included ocular photography. All study procedures and photographic grading were done according to standard protocols.
RESULTS: According to analysis with the Liang-Zeger multiple logistic regression model, people with hypertension were more likely to have posterior subcapsular opacities than people without hypertension (odds ratio, 1.39; 95% confidence interval, 1.05, 1.84). Specific medications for hypertension did not meaningfully affect the risk. Hypertension was associated with increased risk in both those with and without diabetes.
CONCLUSIONS: Hypertension is associated with increased risk of posterior subcapsular opacities. The pathophysiologic mechanisms that may explain the relationship are unknown. Incidence data will give a better indication of temporal relationship between hypertension, medications to lower blood pressure, and lens opacities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733190     DOI: 10.1016/s0002-9394(14)70223-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

1.  Community-based study of cataracts among type 2 diabetics in Kinmen.

Authors:  Tao-Hsin Tung; Jorn-Hon Liu; Fenq-Lih Lee; Shih-Jen Chen; Ching-Yao Tsai; Pesus Chou
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Retrobulbar blood flow in patients with cataract.

Authors:  M C Grieshaber; I Koçak; B Dubler; J Flammer; S Orgül
Journal:  Br J Ophthalmol       Date:  2006-08-02       Impact factor: 4.638

3.  Selected sun-sensitizing medications and incident cataract.

Authors:  Barbara E K Klein; Kristine E Lee; Lorraine G Danforth; Tracie M Schaich; Karen J Cruickshanks; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2010-06-14

4.  Silent myocardial ischemia in glaucoma and cataract patients.

Authors:  E Waldmann; P Gasser; B Dubler; C Huber; J Flammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-10       Impact factor: 3.117

5.  Risk factors for cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino Eye Study.

Authors:  Grace M Richter; Mina Torres; Farzana Choudhury; Stanley P Azen; Rohit Varma
Journal:  Ophthalmology       Date:  2011-12-23       Impact factor: 12.079

6.  The concentration of light in the human lens.

Authors:  J C Merriam
Journal:  Trans Am Ophthalmol Soc       Date:  1996

7.  Association between folate status, diabetes, antihypertensive medication and age-related cataracts in elderly Taiwanese.

Authors:  K-J Chen; W-H Pan; C-J Huang; B-F Lin
Journal:  J Nutr Health Aging       Date:  2011-04       Impact factor: 4.075

8.  Over-expression of translationally controlled tumor protein in lens epithelial cells seems to be associated with cataract development.

Authors:  Min-Jeong Kim; Jungmook Lyu; Kyu-Been Sohn; Miyoung Kim; Myeong-Chan Cho; Choun-Ki Joo; Kyunglim Lee
Journal:  Transgenic Res       Date:  2009-05-29       Impact factor: 2.788

9.  Obesity and risk of age-related eye diseases: a systematic review of prospective population-based studies.

Authors:  Clarissa Ng Yin Ling; Su Chi Lim; Jost B Jonas; Charumathi Sabanayagam
Journal:  Int J Obes (Lond)       Date:  2021-05-07       Impact factor: 5.095

10.  EPHA2 is associated with age-related cortical cataract in mice and humans.

Authors:  Gyungah Jun; Hong Guo; Barbara E K Klein; Ronald Klein; Jie Jin Wang; Paul Mitchell; Hui Miao; Kristine E Lee; Tripti Joshi; Matthias Buck; Preeti Chugha; David Bardenstein; Alison P Klein; Joan E Bailey-Wilson; Xiaohua Gong; Tim D Spector; Toby Andrew; Christopher J Hammond; Robert C Elston; Sudha K Iyengar; Bingcheng Wang
Journal:  PLoS Genet       Date:  2009-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.